These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 34878055)

  • 1. A shadow in the GOLD ABCD classification system: measurement of perception of symptoms in COPD.
    Crisafulli E; Sartori G
    J Bras Pneumol; 2021 Dec; 47(5):e20210389. PubMed ID: 34878055
    [No Abstract]   [Full Text] [Related]  

  • 2. Application of the new GOLD COPD staging system to a US primary care cohort, with comparison to physician and patient impressions of severity.
    Mapel DW; Dalal AA; Johnson PT; Becker LK; Hunter AG
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1477-86. PubMed ID: 26251587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of mortality in patients with chronic obstructive pulmonary disease with the new Global Initiative for Chronic Obstructive Lung Disease 2017 classification: a cohort study.
    Gedebjerg A; Szépligeti SK; Wackerhausen LH; Horváth-Puhó E; Dahl R; Hansen JG; Sørensen HT; Nørgaard M; Lange P; Thomsen RW
    Lancet Respir Med; 2018 Mar; 6(3):204-212. PubMed ID: 29331311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Classification of COPD patients and compliance to recommended treatment in Greece according to GOLD 2017 report: the RELICO study.
    Tzanakis N; Koulouris N; Dimakou K; Gourgoulianis K; Kosmas E; Chasapidou G; Konstantinidis A; Kyriakopoulos C; Kontakiotis T; Rapti A; Gaga M; Kalafatakis K; Kostikas K
    BMC Pulm Med; 2021 Jul; 21(1):216. PubMed ID: 34243744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Value of the Combined Assessment of COPD in Accurate Characterization of Stable COPD.
    Sahadevan A; Cusack R; O'Kelly B; Amoran O; Lane SJ
    Ir Med J; 2016 Jan; 109(1):338-40. PubMed ID: 26904790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GOLD classifications and mortality in chronic obstructive pulmonary disease: the HUNT Study, Norway.
    Leivseth L; Brumpton BM; Nilsen TI; Mai XM; Johnsen R; Langhammer A
    Thorax; 2013 Oct; 68(10):914-21. PubMed ID: 23611880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GOLD assessment of COPD severity in the Clinical Practice Research Datalink (CPRD).
    Rebordosa C; Plana E; Aguado J; Thomas S; García-Gil E; Perez-Gutthann S; Castellsague J
    Pharmacoepidemiol Drug Saf; 2019 Feb; 28(2):126-133. PubMed ID: 29740896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physiological Impairments on Respiratory Oscillometry and Future Exacerbations in Chronic Obstructive Pulmonary Disease Patients without a History of Frequent Exacerbations.
    Zhang Y; Tanabe N; Shima H; Shiraisi Y; Oguma T; Sato A; Muro S; Sato S; Hirai T
    COPD; 2022; 19(1):149-157. PubMed ID: 35392737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of exhaled nitric oxide in patients with chronic obstructive pulmonary disease undergoing laparotomy surgery - The noxious study.
    Logotheti H; Pourzitaki C; Tsaousi G; Aidoni Z; Vekrakou A; Ekaterini A; Gourgoulianis K
    Nitric Oxide; 2016 Dec; 61():62-68. PubMed ID: 27771417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Survival in a cohort of patients with chronic obstructive pulmonary disease according to GOLD 2017 classification].
    Sívori M; Fernández R; Toibaro J; Velásquez Gortaire E
    Medicina (B Aires); 2019; 79(1):20-28. PubMed ID: 30694185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Correlation of Sit-to-Stand Tests with COPD Assessment Test and GOLD Staging Classification.
    Kakavas S; Papanikolaou A; Kompogiorgas S; Stavrinoudakis E; Karayiannis D; Balis E
    COPD; 2020 Dec; 17(6):655-661. PubMed ID: 33023324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Six-minute-walk distance and accelerometry predict outcomes in chronic obstructive pulmonary disease independent of Global Initiative for Chronic Obstructive Lung Disease 2011 Group.
    Durheim MT; Smith PJ; Babyak MA; Mabe SK; Martinu T; Welty-Wolf KE; Emery CF; Palmer SM; Blumenthal JA
    Ann Am Thorac Soc; 2015 Mar; 12(3):349-56. PubMed ID: 25568929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GOLD Classification of COPD: Discordance in Criteria for Symptoms and Exacerbation Risk Assessment.
    Mittal R; Chhabra SK
    COPD; 2017 Feb; 14(1):1-6. PubMed ID: 27723367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary.
    Vogelmeier CF; Criner GJ; Martinez FJ; Anzueto A; Barnes PJ; Bourbeau J; Celli BR; Chen R; Decramer M; Fabbri LM; Frith P; Halpin DM; López Varela MV; Nishimura M; Roche N; Rodriguez-Roisin R; Sin DD; Singh D; Stockley R; Vestbo J; Wedzicha JA; Agustí A
    Am J Respir Crit Care Med; 2017 Mar; 195(5):557-582. PubMed ID: 28128970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of using the new GOLD classification on the distribution of COPD severity in clinical practice.
    Hernández M; García G; Falco J; García AR; Martín V; Ibarrola M; Quadrelli S
    Int J Chron Obstruct Pulmon Dis; 2018; 13():351-356. PubMed ID: 29403272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implications of using the GLI-2012, GOLD and Australian COPD-X recommendations in assessing the severity of airflow limitation on spirometry among an Indigenous population with COPD: an Indigenous Australians perspective study.
    Heraganahally S; Howarth TP; White E; Ben Saad H
    BMJ Open Respir Res; 2021 Dec; 8(1):. PubMed ID: 34952866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of chronic obstructive pulmonary disease severity on symptoms and prognosis in patients with systolic heart failure.
    Arnaudis B; Lairez O; Escamilla R; Fouilloux A; Fournier P; Monteil B; Bouisset F; Arnal JF; Elbaz M; Carrié D; Roncalli J; Pathak A; Galinier M
    Clin Res Cardiol; 2012 Sep; 101(9):717-26. PubMed ID: 22484345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health Care Resource Utilization and Exacerbation Rates in Patients with COPD Stratified by Disease Severity in a Commercially Insured Population.
    Wallace AE; Kaila S; Bayer V; Shaikh A; Shinde MU; Willey VJ; Napier MB; Singer JR
    J Manag Care Spec Pharm; 2019 Feb; 25(2):205-217. PubMed ID: 30698096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary.
    Vogelmeier CF; Criner GJ; Martinez FJ; Anzueto A; Barnes PJ; Bourbeau J; Celli BR; Chen R; Decramer M; Fabbri LM; Frith P; Halpin DM; López Varela MV; Nishimura M; Roche N; Rodriguez-Roisin R; Sin DD; Singh D; Stockley R; Vestbo J; Wedzicha JA; Agusti A
    Respirology; 2017 Apr; 22(3):575-601. PubMed ID: 28150362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection and staging of chronic obstructive pulmonary disease using a computed tomography-based weakly supervised deep learning approach.
    Sun J; Liao X; Yan Y; Zhang X; Sun J; Tan W; Liu B; Wu J; Guo Q; Gao S; Li Z; Wang K; Li Q
    Eur Radiol; 2022 Aug; 32(8):5319-5329. PubMed ID: 35201409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.